Hot line:010-61006450
EN
Chongqing High-end preparation research and development + MAH
About
About Us
Stock(600222)
Founded in 2005,Leadingpharm (stock code 600222) is a high-quality supplier of pharmaceutical CMC, clinical CRO, large and small molecule CDMO and MAH and other full-industry chain services to the world.Leadingpharm has a senior R&D management team of more than 1,300 people, an excellent drug R&D quality management system and rich project experience.Providing customers with customized solutions from product approval to commercial transformation.
Service
Services
-
API and Excipients R&D
Synthesis and Development of Raw and Auxiliary Materials， Research on the Substitution of High-end Auxiliary Materials
-
Preparation R&D
Formulation and Process Development of Generic Drugs, Improved New Drugs and Innovative Drugs
-
Analytical Test
Drug Quality Research，Special Substance TestinResearch on Compatibility of Drug Contact System，Research of External Preparation(Quality, Characteristics, etc.) Other Tests
-
IVIVR
Predicting of PK Curve and Pesticide Effect，Guidance for Clinical Trial Design，Establishment of IVIVR Models，Data Support for Bioequivalence Exemption
-
Clinical CRO
Phase I-IV clinical trial, PK/PD, IIT, medical service, third-party audit
-
CDMO
Large Molecule Drugs CDMO,Small Molecule Drugs CDMO
-
MAH Services
Project Establishment Service, Pharmaceutical Administration Service, Quality Management System Service
-
Other services
Park Services, Financial Services
- Shenyang
- Dalian
- Hangzhou
- Beijing
- Shijiazhuang
- Zhengzhou
- Wuhan
- Changsha
- Guangzhou
- Taiyuan
- Lanzhou
- Xian
- Tianjin
-
Zhengzhou
Preparation R&D base
· Liquid preparation R&D
· Small molecule CDMO platform (solid, injection, oral liquid, etc.)
· Macromolecular CDMO platform (antibodies, recombinant proteins, vaccines, etc.) -
Beijing
Beijing Clinical Management Center
·Medical, operation, Statistics, registration, customer service, etc
Beijing Research Institude
· 10000m2 R & D Laboratory
· API Synthesis, Preparation R & D, Analysis and Testing,Establishment, Registration, etc -
Chongqing
·R&D of high-end solid dosage + pilot test
·Innovative drug R&D
·MAH project customization
-
Hangzhou
Hangzhou High-end Pediatric Preparation R & D Base
·Improved new drugs, traditional Chinese medicine, OTC
NEWS
News
- Company News
-
Strategic Cooperation | The Intelligent Development Joint Research Center for Improved New Drugs Built by Leadingpharm and Peking University Third Hospital has been Officially Launched
2022-11-12 -
Leadingpharm (Chongqing) Medical Technology Has Been Grandly Opened, Which Will Further Improve the Strategic Layout of CXO in the Whole Country!
2022-11-01 -
Alumni Exchange | CEIBS EMBA 2021 Class 4 Visited Leadingpharm
2022-08-24
010-61006450
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
